278 related articles for article (PubMed ID: 26446098)
1. Rising drug prices drive US manufacturers' revenues, analysis finds.
McCarthy M
BMJ; 2015 Oct; 351():h5376. PubMed ID: 26446098
[No Abstract] [Full Text] [Related]
2. Trends in manufacturer prices of brand name prescription drugs used by older Americans--first quarter 2004 update.
Gross DJ; Schondelmeyer SW; Raetzman SO
Issue Brief (Public Policy Inst (Am Assoc Retired Pers)); 2004 Jun; (IB69):1-12, 1-2. PubMed ID: 15368653
[TBL] [Abstract][Full Text] [Related]
3. Screaming for relief.
Cooper M
Time; 1999 Nov; 154(21):38-42, 44. PubMed ID: 10622838
[No Abstract] [Full Text] [Related]
4. Proposal To Use VA Price As a Benchmark Is off the Mark.
Kirkner RM
Manag Care; 2016 Dec; 25(12):14-15. PubMed ID: 28121548
[TBL] [Abstract][Full Text] [Related]
5. Who's really raising drug prices?
Zagorin A
Time; 1999 Mar; 153(9):46-8. PubMed ID: 10346086
[No Abstract] [Full Text] [Related]
6. Will lower drug prices jeopardize drug research? A policy fact sheet.
Light DW; Lexchin J
Am J Bioeth; 2004; 4(1):W1-4. PubMed ID: 15035915
[No Abstract] [Full Text] [Related]
7. Pharmaceutical costs. An overview and analysis of legal and policy responses by the states.
Latham SR
J Leg Med; 2003 Jun; 24(2):141-73. PubMed ID: 12775406
[No Abstract] [Full Text] [Related]
8. Pharmacoeconomics: the new dismal science.
Luchins DJ
Adm Policy Ment Health; 2004 May; 31(5):425-7. PubMed ID: 15379388
[No Abstract] [Full Text] [Related]
9. Pharmaceuticals and medical devices: cost savings.
Steiner DJ
Issue Brief Health Policy Track Serv; 2013 Dec; ():1-32. PubMed ID: 24482891
[No Abstract] [Full Text] [Related]
10. Coordinating on lower prices: pharmaceutical pricing under political pressure.
Ellison SF; Wolfram C
Rand J Econ; 2006; 37(2):324-40. PubMed ID: 17290546
[TBL] [Abstract][Full Text] [Related]
11. The effect of drug reimportation on managed care pharmacy.
Penna P
Manag Care Interface; 2003 Jul; 16(7):41-2. PubMed ID: 12908216
[No Abstract] [Full Text] [Related]
12. The hidden cost of low prices: limited access to new drugs in India.
Berndt ER; Cockburn IM
Health Aff (Millwood); 2014 Sep; 33(9):1567-75. PubMed ID: 25201661
[TBL] [Abstract][Full Text] [Related]
13. Pharmaceuticals in U.S. health care: determinants of quantity and price.
Berndt ER
J Econ Perspect; 2002; 16(4):45-66. PubMed ID: 15179978
[No Abstract] [Full Text] [Related]
14. Exploring the rise in American pharmaceutical prices.
Marwaha A
Pharos Alpha Omega Alpha Honor Med Soc; 2002; 65(2):11-5. PubMed ID: 12099112
[No Abstract] [Full Text] [Related]
15. American pharmaceutical prices.
Alagona P
Pharos Alpha Omega Alpha Honor Med Soc; 2002; 65(4):58. PubMed ID: 12592980
[No Abstract] [Full Text] [Related]
16. RX for nosebleed prices.
Greenwald J
Time; 2001 May; 157(20):42-3. PubMed ID: 11383109
[No Abstract] [Full Text] [Related]
17. Prescription drug manufacturers get warning on prices.
Margolis RE
Healthspan; 1993 Mar; 10(3):19-20. PubMed ID: 10125344
[No Abstract] [Full Text] [Related]
18. Projecting future drug expenditures--1998.
Mehl B; Santell JP
Am J Health Syst Pharm; 1998 Jan; 55(2):127-36. PubMed ID: 9465976
[TBL] [Abstract][Full Text] [Related]
19. What price e.commerce?
Nat Biotechnol; 2000 Jul; 18(7):693. PubMed ID: 10888793
[No Abstract] [Full Text] [Related]
20. Pharmacoeconomics under defined contributions and tiered formularies.
Lyles A
Clin Ther; 2001 Sep; 23(9):1568-9. PubMed ID: 11589268
[No Abstract] [Full Text] [Related]
[Next] [New Search]
